LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Recalls and defects › 9 Jun 2025
Medicines recall

Paracetamol 500mg Tablets

Issued on 9 Jun 2025 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Affected batches: 2312010 (30/11/2027), 2312011 (30/11/2027)
Check the batch number on the pack. The medicine remains licensed; other batches are not affected.
Class 2 recall · DMRC-35796576 · PL: 33414/0126 · licence holder: Chelonia Healthcare Limited · active ingredient: Paracetamol · licence PL: 33414/0126
MHRA alert on GOV.UK ↗ All events: Paracetamol 500mg Tablets

What this means

The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.

Class 2 recall · DMRC-35796576

ProductLicenceActive ingredientGTIN
Paracetamol 500mg TabletsPL: 33414/0126Paracetamol05060014445506

Batches (expiry): 2312010 (30/11/2027), 2312011 (30/11/2027)

Background: Chelonia Healthcare Limited is recalling Batch 2312010 of Paracetamol 500mg Tablets (POM) in Genesis livery as a precautionary measure following a small number of complaints of discoloured tablets found within some packs, reported by healthcare professionals. This issue has only been identified in Batch 2312010, however as a precautionary measure, Batch 2312011 is also being recalled to mitigate any risk, as the investigation and analysis remain ongoing. Advice for Healthcare Professionals:

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.